HCPCS Level IIdrugActive
J9380
Inj teclistamab cqyv 0.5 mg
BETOS: O1E
Effective: 2023-07-01
Description
Injection, teclistamab-cqyv, 0.5 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Tecvayli
Manufacturer
Janssen Biotech, Inc.
HCPCS Dosage
0.5 MG
Billing Units
60.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.